Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.

相似書籍

• Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
  由: Melcher, A. A., et al.
  出版: (1996)
• Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
  由: Sumpter, K, et al.
  出版: (2005)
• Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
  由: Waters, J S, et al.
  出版: (1999)
• Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.
  由: Bonnefoi, H., et al.
  出版: (1996)
• The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil.
  由: Crawley, C., et al.
  出版: (1998)